Expired activity
Please go to the PowerPak homepage and select a course.

An Interprofessional Approach to Managing Multidrug-Resistant Bacterial Infections

Provided by American Academy of CME, Inc.

This educational activity is supported by an educational grant from Merck.

Release date

February 26, 2021

Expiration date

February 26, 2022

Estimated time to complete

1.5 hours

Activity Description

The number of formally ID-trained pharmacists and physicians are limited across the country. This means that there is a growing role for general pharmacists and ID physicians to optimally manage their patients’ antibiotics in the hospital or outpatient setting as well as fulfill necessary expert roles in antibiotic stewardship programs. In order to do so, physicians and pharmacists will need education regarding the current state of drug-resistant infections and current/emerging antibiotic therapies.

Physicians and pharmacists will need to understand the nuances of new antibiotics for treatment of multidrug-resistant bacteria and its role on the hospital formulary. Along with enhanced knowledge of this complex area of infectious diseases management, the ability to effectively communicate this knowledge and educate others on the healthcare team will be fostered and fulfilled. The recommended activity will engage the ID physician and pharmacist in multidrug-resistant bacteria patient care and management through a care team approach.

Faculty Educators

Pinki J. Bhatt, MD
Assistant Professor, Division of Infectious Diseases
Associate Program Director, Infectious Disease Fellowship Program
Rutgers Robert Wood Johnson Medical School
Adjunct Assistant Professor, Rutgers Ernest Mario School of Pharmacy, New Brunswick, NJ

Pinki J. Bhatt is an Assistant Professor in the Division of Allergy/Immunology and Infectious Diseases at the Rutgers Robert Wood Johnson Medical School and an adjunct Assistant Professor at the Rutgers Ernest Mario School of Pharmacy in New Brunswick, NJ. She is also an Associate Program Director for the Infectious Diseases Fellowship Program for the Department of Medicine at Rutgers Robert Wood Johnson Medical School.

Navaneeth Narayanan, PharmD, MPH, BCIDP, BCPS
Clinical Associate Professor
Department of Pharmacy Practice and Administration
Rutgers University Ernest Mario School of Pharmacy

Navaneeth (Nav) Narayanan is a Clinical Associate Professor in the Department of Pharmacy Practice and Administration at the Rutgers University Ernest Mario School of Pharmacy and jointly practices as an Infectious Diseases Clinical Pharmacist and Antimicrobial Stewardship Co-Director at Robert Wood Johnson University Hospital in New Brunswick, NJ.  He is also an Adjunct Assistant Professor in the Division of Infectious Diseases at Rutgers Robert Wood Johnson Medical School and an Adjunct Faculty/Medical Consultant for the Global Tuberculosis Institute at Rutgers New Jersey Medical School.  He also serves as an Advisor for the CLSI Antimicrobial Susceptibility Testing Subcommittee.  

Target Audience

This activity is designed for pharmacists and infectious disease physicians engaged in the management of multidrug-resistant bacterial infections.

Learning Objectives

Upon completing this activity, learners should be better able to:

  1. Describe the epidemiology and mechanisms of drug-resistance among Gram-negative (GNB) and Gram-positive (GPB) bacterial infections
  2. Analyze the pharmacology and antibacterial activity of current and emerging antibiotic therapies for multidrug-resistant (MDR) GNB and GPB infections
  3. Explain the clinical evidence and clinical utility of new antibiotic therapies for MDR GNB and MDR GPB infections
  4. Evaluate how the interprofessional team can work together to manage antibiotic therapies for MDR GNB and MDR GPB infections and their roles as antibiotic stewardship program members


Joint Accreditation StatementIn support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


acpeThis activity provides 1.5 ACPE contact hours (0.15 CEUs) of continuing education credit. Universal Activity Number List: JA4008191-0000-21-002-H01-P; Application.


Disclosure Statement

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are able to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.

Disclosures are as follows:


Pinki J. Bhatt, MD has the following disclosures to report:
No relevant financial relationships with any commercial interests.

Navaneeth Narayanan, PharmD, MPH, BCPS has the following disclosures to report:
Grant Recipient/Research Support-Astellas
Promotional Speaker’s Bureau-Astellas

Planning Committee

John JD Juchniewicz, MCIS, CHCP, Wendy Gloffke, PhD and Paul J. Miniter, MS
No relevant financial relationships with any commercial interests.

Content Reviewer
Philip Coco, PharmD
No relevant financial relationships with any commercial interests.

American Academy of CME, Inc (Academy) requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
This activity will review off-label or investigational information.


The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CPE credit for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately.

For pharmacists, a statement of credit will be issued through CPE Monitor in 4 weeks. Only learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.

Hardware/Software Requirements

Please ensure the computer you plan to use meets the following minimum requirements:

  • Operating System: Windows 98 or higher & Macintosh 2.2 or higher
  • Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
  • Broadband Internet connection:Cable, High-speed DSL & any other medium that is internet accessible
  • Monitor Screen Resolution: 320 x 480 or higher
  • Media Viewing Requirements: Adobe Reader, Microsoft Powerpoint, Flash Player & HTML5


For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm


For any questions, please contact: CEServices@academycme.org


© 2021. This CPE/CE-certified activity is held as copyrighted © by American Academy of CME, Inc. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).